50KRW
3.51 BKRW
134.91 BKRW
29.77 M
About HANALL BIOPHARMA
Sector
Headquarters
Daejeon
Founded
1973
Website
ISIN
KR7009420001
FIGI
BBG000BG01Z0
HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceuticals. It offers products such as medicine for digestion, high blood pressure, cerebrovascular disease, myocardial infarction, anti-diabetics, antibiotics, gastrointestinal, bone structure, erectile dysfunction, hives, and other pharmaceutical products. The company was founded by Byeong-Tae Kim on November 20, 1973 and is headquartered in Daejeon, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 009420 is 34450 KRW — it has decreased by 2.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HANALL BIOPHARMA stocks are traded under the ticker 009420.
009420 stock is 3.34% volatile and has beta coefficient of 1.04. Check out the list of the most volatile stocks — is HANALL BIOPHARMA there?
HANALL BIOPHARMA revenue for the last quarter amounts to 32.60 B KRW despite the estimated figure of 33.15 B KRW. In the next quarter revenue is expected to reach 32.95 B KRW.
Yes, you can track HANALL BIOPHARMA financials in yearly and quarterly reports right on TradingView.
009420 stock has risen by 9.02% compared to the previous week, the month change is a 13.88% fall, over the last year HANALL BIOPHARMA has showed a 66.02% increase.
009420 net income for the last quarter is −2.86 B KRW, while the quarter before that showed 318.81 M KRW of net income which accounts for −998.06% change. Track more HANALL BIOPHARMA financial stats to get the full picture.
Today HANALL BIOPHARMA has the market capitalization of 1.79 T, it has increased by 5.64% over the last week.
No, 009420 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 009420 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANALL BIOPHARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANALL BIOPHARMA technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANALL BIOPHARMA stock shows the buy signal. See more of HANALL BIOPHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on HANALL BIOPHARMA future price: according to them, 009420 price has a max estimate of 46000.00 KRW and a min estimate of 45000.00 KRW. Read a more detailed HANALL BIOPHARMA forecast: see what analysts think of HANALL BIOPHARMA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANALL BIOPHARMA EBITDA is 4.99 B KRW, and current EBITDA margin is 3.70%. See more stats in HANALL BIOPHARMA financial statements.